SEL HÉMIFUMARATE D'ACIDE 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUOROMÉTHYL-BENZYLOXYIMINO)-ÉTHYL]-2-ÉTHYL-BENZYL]-AZÉTIDINE-3-CARBOXYLIQUE POUR UNE UTILISATION DANS LE TRAITEMENT DES MALADIES LIEES AUX LYMPHOCYTES
- 专利权人:
- Novartis AG
- 发明人:
- 申请号：
- EP13177190.9
- 公开号：
- EP2676953B1
- 申请日:
- 2009.12.16
- 申请国别(地区):
- EP
- 年份:
- 2017
- 代理人:
- 摘要：
- This invention relates to a hemifumarate salt of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I) for use in medical treatment and to pharmaceutical compositions comprising this salt.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- SEL HÉMIFUMARATE D'ACIDE 1-Ý4-Ý1-(4-CYCLOHEXYL-3-TRIFLUOROMÉTHYL-BENZYLOXYIMINO¨-ÉTHYL¨-2-ÉTHYL-BENZYL¨-AZÉTIDINE-3-CARBOXYLIQUE
- HEMIFUMARATE SALT OF 1-(4-(1-(4-CYCLOHEXYL-3 -TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL)-2-ETHYL-BENZYL)-AZETIDINE-3-CARBOXYLIC ACID FOR USE IN THE TREATMENT OF LYMPHOCYTE MEDIATED DISEASES
- Hemifumarate salt of 1- [4- [1- (4-cyclohexyl-3-trifluoromethyl-benzyloxyimino) -ethyl] -2-ethyl-benzyl] -acetidine-3-carboxylic acid for use in the treatment of lymphocyte-mediated diseases
- HEMIFUMARATE SALT OF 1-[4-[1-(4-CYCLOHEXYL-3 -TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL]-2-ETHYL-BENZYL]-AZETIDINE-3-CARBOXYLIC ACID FOR USE IN THE TREATMENT OF LYMPHOCYTE MEDIATED DISEASES
- HEMIFUMARATE SALT OF 1-(4-{1-[4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO]-ETHYL}-2-ETHYL-BENZYL)-A ZETIDINE-3-CARBOXYLIC ACID
